Normal view MARC view ISBD view

Luckprom, P

Adenosine triphosphate stimulates RANKL expression through P2Y1 receptor-cyclo-oxygenase-dependent pathway in human periodontal ligament cells. [electronic resource] - Journal of periodontal research Jun 2010 - 404-11 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1600-0765

Standard No.: 10.1111/j.1600-0765.2009.01256.x doi

Subjects--Topical Terms:
Adenosine Diphosphate--analogs & derivatives
Adenosine Triphosphate--pharmacology
Biomechanical Phenomena
Bone Remodeling--physiology
Bone Resorption--physiopathology
Cells, Cultured
Cyclic AMP-Dependent Protein Kinases--antagonists & inhibitors
Cyclooxygenase 2--drug effects
Cyclooxygenase 2 Inhibitors--pharmacology
Dinoprostone--antagonists & inhibitors
Enzyme Inhibitors--pharmacology
Estrenes--pharmacology
Humans
Indomethacin--pharmacology
Isoquinolines--pharmacology
NF-kappa B--antagonists & inhibitors
Periodontal Ligament--cytology
Phosphodiesterase Inhibitors--pharmacology
Purinergic P2 Receptor Antagonists
Pyrrolidines--pharmacology
Pyrrolidinones--pharmacology
RANK Ligand--antagonists & inhibitors
RNA, Small Interfering--pharmacology
Receptors, Purinergic P2--drug effects
Receptors, Purinergic P2Y1
Sulfonamides--pharmacology
Thiocarbamates--pharmacology
Type C Phospholipases--antagonists & inhibitors